AQEMIA is building AI-driven drug discovery workflows, and this role is key to scaling pre-program screening. You will own end-to-end QEMI virtual screening and hit expansion campaigns, including structure selection and target preparation, coordinating with compute and engineering teams to ensure high-quality, reproducible results.
Within 12 months, you will help standardize a resilient screening workflow to accelerate hit discovery across programs, contributing to platform and product
#J-18808-LjbffrAI-Driven Computational Chemist — Pre-Programs (Hybrid) employer: Aqemia.Com
AQEMIA is an exceptional employer dedicated to innovation in drug discovery, offering a unique opportunity for Computational Chemists to make a significant impact on healthcare. With a world-class interdisciplinary team based in the vibrant heart of Paris, employees benefit from a collaborative work culture, flexible arrangements, and strong financial backing, all while contributing to groundbreaking research that addresses critical medical needs. Join us to be part of a mission-driven company where your expertise can shape the future of medicine and foster your professional growth.
